DOTmed December 11, 2023
British AI company Bering Limited has nabbed 510(k)-clearance for its AI-powered chest X-ray triage solution, BraveCX, which is designed to identify pleural effusion, pneumothorax and other life-threatening conditions from chest X-rays in patients and triage and prioritize cases based on criticality.
The radiology-based computer-assisted triage and notification software is trained on over one million chest X-rays captured in different clinical settings. Bering added another 50,000 scans labeled by board-certified radiologists to further improve its accuracy and ensure the algorithm’s performance aligns with expert radiologist interpretations.
Bering says it is meant to provide a “second opinion” to physicians to help them make clinical decisions quicker and reduce time-to-diagnosis in urgent cases.
“FDA clearance means BraveCX prioritizes patient safety, whilst still delivering...
Today's Sponsors
Today's Sponsor